Oversight and Investigations

Oversight and Investigations

In the First Session of the 112th Congress, the Subcommittee on Oversight and Investigations:

  • Held 23 hearings.
  • Sent over 80 letters requesting documents, briefings, interviews, and other information.
  • Reviewed over 350,00 pages of documents

Solyndra Investigation

As Chairman of the Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, I have led the investigation into the Obama Administration’s rushed decision to loan Solyndra, a California manufacture of solar panels, $535 million in taxpayer money when incredibly the Department of Energy (DOE) knew in August of 2009 that Solyndra would go bankrupt in September of 2011. The investigation has also uncovered that during the restructuring of the Solyndra loan, DOE made the unprecedented decision to allow two venture capital firms to be paid back before taxpayers if Solyndra failed – a clear violation of the Energy Policy Act of 2005.

There is great cause for alarm over political influence contaminating the DOE loan guarantee program. Documents produced by the White House reveal a disturbing prevalence of wealthy donors and bundlers littered throughout the loan guarantee process, with direct access to the President’s West Wing inner circle. In addition, subpoenas for records were issued to the White House and the Executive Office of the Vice President. Those subpoenas have uncovered that the White House had advanced notice that Solyndra planned to fire workers and the Energy Department urged Solyndra to postpone the layoffs until after the 2010 election.

Please rest assured that I will continue to investigate all of the Department of Energy loan guarantee recipients and that the politicization of the loan guarantee process is a subject our investigation does not take lightly — we are looking into this and will see where it leads us.

 

Medicare: Waste, Fraud & Abuse

It is estimated that Medicare looses $60 - $90 billion dollars every year in Medicare fraud.  This number is an unofficial estimate by third parties because the Centers for Medicare and Medicaid Services (CMS) does not estimate how much fraud occurs in the program.  It is unsettling that the Administration cannot determine or estimate how much fraud occurs in a $600 billion a year program.  Medicare spending is estimated to grow at a rate of 4-6% annually.

Unfortunately, this is only one aspect of the problems of Medicare.  Even existing Medicare programs have failed to properly manage benefits.  The Medicare Secondary Payer (MSP) system was designed to collect funds from insurance companies when available, making Medicare a secondary payer of benefits.  However, in a hearing, the Chief Financial Officer and Director of the Office of Financial Management at CMS was unable to answer numerous questions on financial costs of the MSP program and collections.  Mismanagement and inefficiencies have cost the American taxpayers billions in unnecessary payments.

I have introduced the Promoting Responsibility in Medical Expenditures (PRIME, HR 3474) to help reduce the level of waste, fraud and abuse in the Medicare, Medicare and Child Health Insurance Programs (CHIP).  PRIME would increase criminal and civil penalties for those who defraud the system and require the Centers for Medicare and Medicaid Services (CMS) to measure how much fraud occurs in the Medicare and Medicaid programs.  It also protects CMS’s predictive analytics algorithm similar to that used by credit card companies to deter fraud.  It would also standardize some Medicare submission forms and require validation of prescriber numbers, beneficiary numbers, and provider numbers before a payment is made to stop fraud before it occurs rather than chasing criminals after a fraudulent payment is made.

 

Energy and Commerce Oversight and Investigations Subcommittee Hearings

11/17/2011

The Solyndra Failure: Views from DOE Secretary Chu

10/26/2011

CLASS Cancelled: An Unsustainable Program and Its Consequences for the Nation’s Deficit

10/14/2011

Continuing Developments Regarding the Solyndra Loan Guarantee

10/12/2011

Cutting EPA Spending

10/5/2011

Administration Efforts on Line-by-Line Budget Review

9/26/2011

Impact of Medical Device and Drug Regulation on Innovation, Jobs and Patients: A Local Perspective.

9/23/2011

From DOE Loan Guarantee to Bankruptcy to FBI Raid: What Solyndra's Executives Knew

9/22/2011

Regulatory Reform Series #7 - The EPA’s Regulatory Planning, Analysis, and Major Actions

9/14/2011

Solyndra and The DOE Loan Guarantee Program

8/9/2011

Field Hearing: EPA’s Takeover of Florida’s Nutrient Water Quality Standard Setting: Impact on Communities and Job Creation

7/26/2011

Cybersecurity: An Overview of Risks to Critical Infrastructure

7/20/2011

Regulatory Reform Series #5 - FDA Medical Device Regulation: Impact on American Patients, Innovation and Jobs

7/14/2011

Subcommittee on Oversight and Investigations business meeting to consider subpoena for OMB records relating to DOE's loan guarantee to Solyndra, Inc.

7/7/2011

The Views of the Independent Agencies on Regulatory Reform

6/24/2011

OMB's Role in the DOE Loan Guarantee Process

6/22/2011

Protecting Medicare with Improvements to the Secondary Payer Regime

6/13/2011

The Views of the Department of Health and Human Services on Regulatory Reform: An Update

6/3/2011

The Views of the Administration on Regulatory Reform: An Update

5/3/2011

White House Transparency, Visitor Logs and Lobbyists

4/13/2011

Import Safety: Status of FDA’s Screening Efforts at the Border

4/6/2011

The U.S. Government Response to the Nuclear Power Plant Incident in Japan

4/1/2011

The PPACA’s High Risk Pool Regime: High Cost, Low Participation

3/17/2011

Oversight of DOE Recovery Act Spending

3/2/2011

Waste, Fraud, and Abuse: A Continuing Threat to Medicare and Medicaid

2/16/2011

Health Care Issues Involving the Center for Consumer Information and Insurance Oversight

1/26/2011

The Views of the Administration on Regulatory Reform